Skye Bioscience, Inc. (SKYE)
1.00
+0.04
(+3.89%)
USD |
NASDAQ |
Jan 16, 16:00
1.025
+0.02
(+2.50%)
After-Hours: 20:00
Skye Bioscience SG&A Expense (TTM): 16.93M for Sept. 30, 2025
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Perspective Therapeutics, Inc. | 31.53M |
| Theravance Biopharma, Inc. | 75.94M |
| Viking Therapeutics, Inc. | 52.36M |
| Kyntra Bio, Inc. | 28.80M |
| Myomo, Inc. | 32.71M |